Unknown PHASE4 INTERVENTIONAL 1-arm NCT05555797

Excimer Laser With Topical Agents in Psoriasis Vulgaris

Efficacy of Excimer Laser Combined With Either Topical Tazarotene or Topical Betamethasone Valerate Versus Excimer Laser Alone in Treatment of Localized Chronic Plaque Psoriasis; Clinical and Dermoscopic Study

Sponsor: Assiut University

Conditions Psoriasis

Interventions 308nm Excimer laser Betamethasone Valerate Tazarotene Topical Gel

Updated 5 times since 2022 Last updated: Oct 15, 2022 Started: Oct 30, 2022 Primary completion: Sep 30, 2023 Completion: Sep 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Psoriasis, this trial is ongoing. The trial is conducted by Assiut University and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Nov 2024 — Present [monthly]

Unknown PHASE4

Status: Not Yet Recruiting → Unknown
Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4
Nov 2022 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4
Sep 2022 — Nov 2022 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Assiut University

Data source: Assiut University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.